The statement is an outline of what is presently known about risk elements customary to both heart disease and breast cancer, the probable heart damage for few breast cancer treatments and recommended procedure to halt or minimize the damage.
It said an unprecedented number of women are surviving the disease yet face a risk of developing heart problems, in part due to their cancer treatments. Current treatment for breast cancer can have a negative effect on cardiovascular health such as left ventricular dysfunction and accelerated CVD; this may influence cancer treatment decisions by the patient and provider among women with pre-existing CVD.
"The intent of the paper is certainly not to say don't treat breast cancer", Mehta said.
An estimated 47 million women in the USA have heart disease.
Some studies suggest that administering common chemotherapy therapies in new ways may reduce heart disease risks. "Health care is changing such that a cancer patient often does not see an oncologist after completion of therapy". "Let's give these drugs and treatments to people who need them - the risk-benefit is more favorable - and let's do all we can to determine who is unlikely to benefit from the drugs and spare them the risks". However, heart disease prior to, during or after cancer treatment can impact outcomes. That's a problem because heart failure caused by a chemo drug like doxorubicin is treated differently than heart failure from a heart attack, he said.
Have you or someone in your family suffered from prostate cancer, and if so are you up to talking about that experience?More news: Dravid full of pride after India U19 World Cup triumph
It's well-known that treatments such as chest radiation and certain drugs can damage the heart, sometimes leading to chronic heart disease.
The American Heart Association released a scientific statement, warning that some breast cancer therapies pose serious risks of heart disease.
While it's not a symptoms of the cancer itself, it could be a sign of the disease: frequent peeing at night is linked to a possible tumour causing the prostate gland to swell.
"Adriamycin-induced congestive heart failure symptoms can show up three to five years after treatment and easily be missed by an internist or ER doctor who does not see a lot of these patients", he said.
Prostate cancer is also more common among men of African-Caribbean and African descent than in men of Asian descent. "If you compare to 10, 20 years ago, survival rates are generally getting better, that is certainly the case for both prostate and breast [cancer]".
"The introduction of precision medicine, a screening program and a weighty research boost has no doubt played an important role in reducing the number of women who die from the disease", she said. "But there are side effects from these cancer treatments, and we're trying to recognize it in the very early phases so that we may be able to mitigate the heart effects and avoid significant heart damage".